Trainees in medical oncology, radiation oncology and surgical oncology are invited to attend the Breast Cancer Trials inaugural Trainee Day, at the 43rd Annual Scientific Meeting.

This is a free multi-disciplinary session, with both presentations and MDT panel discussions from leading Australian and International breast cancer experts.

The Trainee Day will be held on Saturday 30 July from 9am – 3pm, at The Langham Melbourne.

The day will focus on the management of early breast cancer with updates on the latest in evidenced based research. Topics to be covered include:

  • Management of the axilla
  • Radiotherapy post mastectomy – who receives it and how to treat it
  • How, what and when to use gene expression profiling tests such as Oncotype DX
  • Immunotherapy in triple negative, early-stage breast cancer – balancing the benefits and risks
  • Controversies in the management of DCIS
  • Fertility preservation and pregnancy after breast cancer
  • Genetics update and risk management in the clinic

This is a fantastic networking and professional development opportunity with leading BCT researchers and other trainees.

For more information please contact the ASM Secretariat at asm@bctrials.org.au

To register for this free event, click here.

Play Video

Saturday 30 July 2022 Trainee & Early Career Day Program

Trainee Session: 9:00 am – 3:30 pm

Session Chairs:

9:00 am

Session Chair – Dr Sofia Mason and Dr Katherine Francis

Introduction to training session

9:10 am

(20p:10q)

Professor Laura Esserman

Management of the Axilla

9:40am

(20p:10q)

Dr Miriam Boxer

Adjuvant Radiotherapy – Opportunities for de-escalation

10.10 am

(20p:10q)

Dr Belinda Kiely

Genomic Profiling – How, When and What?

10:40 am

Break

 

11:00 am

(20p:10q)

Dr Reuben Broom

What’s new in neoadjuvant therapy for Triple Negative Breast Cancer

11:30 am

(20p:10q)

Dr Holly Keane

Controversies in DCIS

12:00 pm

(20p:10q)

Professor Ann Partridge

Fertility and pregnancy after breast cancer

12.30 pm

(20p:10q)

Dr Milita Zaheed

Genetics Update/ Risk Management in clinic

1:00 pm

Lunch

 

1:45 pm

Session Chair – Dr Sofia Mason and Dr Katherine Francis

Welcome back/ Open to MDT and introduce panel

1:50 pm

Dr Nick Zdenkowski

Trainee Opportunities with Breast Cancer Trials

2:00 pm

MDT Panel discussion with panel

Panel: Ms Leslie Gilham, Dr Nick Zdenkowski, Professor Ann Partridge, Milita Zaheed, A/Prof Lesley Stafford, Dr Reuben Broom, Dr Miriam Boxer.

 

Chaired by: Dr Sofia Mason and Dr Katherine Francis

MDT Panel Case Base discussion

3:30 pm

Canapés and Drinks

 

Trainee & Early Career Day Speakers

Leslie Gilham

Chair of the Consumer Advisory Panel (CAP) of Breast Cancer Trials, participant in the TEXT Clinical Trial, and Clinical Trials Advocate

Miriam Boxer

Member of the RANZCR Professional Practice Committee & previously a Director of Training at Liverpool & Campbelltown Hospitals

Ann Partridge

Professor of Medicine, Harvard Medical School, & Vice Chair of Medical Oncology, Dana-Faber Cancer Institute

Milita Zaheed

Medical Oncologist and staff specialist in Cancer Genetics and Medical Lead for ACT Cancer Genetics Service

Laura Esserman

Professor of Surgery and Radiology at the University of California, San Francisco (UCSF) and director of the UCSF Breast Care Clinic

Nicholas Zdenkowski

Medical Oncologist & Advisor with Breast Cancer Trials, consulting across the Hunter Region in NSW Australia